The U.S. Supreme Court's decision on Wednesday that shipping a single component of a patented invention to be combined with others overseas is not patent infringement eliminates liability in that situation but leaves parties to battle in lower courts over what constitutes infringement in other scenarios.
Songkick, a concert ticketing startup, tacked on new claims Wednesday in its ongoing antitrust suit against Live Nation and Ticketmaster over their alleged monopoly of ticket sales by claiming that one of its former executives who landed at Ticketmaster unlawfully accessed its computer systems to steal trade secrets.
A New Jersey federal judge on Wednesday found that Dr. Reddy’s Laboratories Inc.’s planned generic version of Helsinn Healthcare SA’s anti-nausea drug Aloxi infringes three patents for the drug and rejected Dr. Reddy’s contention that two of those patents are invalid.
Michael Jackson’s estate on Wednesday called a business appraisal expert to testify at the Los Angeles tax trial over the estate's value at Jackson’s death, with the expert testifying that child molestation allegations had plunged the singer's publicity rights into “nuclear winter,” reducing their value to just $3 million.
A genomic research center affiliated with the Massachusetts Institute of Technology and Harvard University scored a key win involving its patents on groundbreaking gene-editing technology when the Patent Trial and Appeal Board said Wednesday that the patents don’t interfere with claims filed by a rival research team.
A Delaware federal judge has refused to allow a company that indemnified Verizon in a patent suit and settled with the patent owner to get out of the deal after the patent was invalidated under Alice, saying the agreement was clearly complete before the invalidity ruling.
Sazerac, the distiller behind Fireball whiskey, accused a Florida spirits company Wednesday of gearing up to launch a product that closely mimics the trade dress of the popular cinnamon liquor.
A Texas federal judge on Wednesday signed off on an order that ended a lawsuit against travel website Hotels.com brought by a Texas entity alleging computer program patent infringement.
A New Jersey federal judge on Tuesday rejected three insurers' request to dismiss claims that they refused in bad faith to defend or indemnify a cigarette filter manufacturer in trademark litigation over a filter product called "Nic Out," finding that the manufacturer's complaint contains sufficient supporting facts.
Ariosa urged the Federal Circuit Tuesday to deny Illumina’s mandamus petition arguing that courts are applying the America Invents Act’s estoppel provision too narrowly and allowing inter partes review petitioners to make too many arguments in district court after a Patent Trial and Appeal Board decision, saying mandamus isn’t warranted.
Palantir Technologies Inc., a data analytics firm specializing in U.S. intelligence and defense, urged a California federal judge on Wednesday to remand its trade secrets allegations that a former adviser tried to patent its ideas, saying its request for an injunction blocking his patent application does not make it a federal case.
First American Title Insurance Co. told a Utah federal court Tuesday that it shouldn’t let a competitor receive a new trial over claims it illegally poached First American’s employees, calling its Dec. 16 jury award of more than $3 million reasonable and well supported by the facts.
The Federal Trade Commission's new acting chairwoman vowed Wednesday to take action if companies abuse their patent rights but emphasized the need to strike the right balance on antitrust enforcement over intellectual property rights.
A New Jersey federal judge on Tuesday blocked Emcure Pharmaceuticals Ltd. and Teva Pharmaceutical Industries Ltd. from moving forward with generic versions of Sunovion Pharmaceuticals Inc.’s bipolar disorder medication Latuda, and that same day, Sunovion filed another infringement suit against MSN Laboratories and Sandoz Inc. over the drug.
The studio behind the “RoboCop” movie franchise has reached a settlement to end a trademark fight with an electronics company called Robocopp, according to court papers filed in California federal court on Tuesday.
U.S. Steel Corp. announced Wednesday that it will withdraw allegations that its Chinese competitors hacked and stole trade secrets for the production of high-tech steel, citing the “unbearable burden” it faced in arguing the case before the U.S. International Trade Commission.
A Nevada federal judge ruled Wednesday that a Hoover Dam cafe owner must pay a former friend whose copyrighted sculpture he unfairly used to advertise his restaurant around $400,000 in attorneys’ fees for a second trial in the case, rather than the more than $900,000 the artist has requested.
Two dozen copyright law professors urged the Second Circuit on Tuesday to overturn a district court’s $3.5 million judgment against music sharing service ReDigi for infringing Capitol Records' copyrights, saying the decision undermines the law's careful balance between the rights of copyright holders and purchasers.
Samsung dodged part of a suit brought by a company who claims the tech giant infringed its augmented reality technology patents with Samsung Galaxy smartphones when a California federal judge tossed trade secrets claims Tuesday, finding the statute of limitations had expired.
A New York federal judge on Wednesday dismissed copyright infringement claims against ABC, NBC, Yahoo and COED Media, saying their use of video and screen grabs from a birth streamed over Facebook Live fell squarely within fair use.
The Federal Circuit on Wednesday reversed a California federal court’s decision that it lacked jurisdiction to hear Xilinx’s suit seeking declaratory judgment that it does not infringe two Papst Licensing memory test patents, ruling that California is a reasonable venue for the case.
The Federal Circuit has yet to construe the America Invents Act's on-sale bar provisions. However, recent Patent Trial and Appeal Board decisions offer some guidance on this issue, say Roger Lee and David Leibovitch of Buchanan Ingersoll & Rooney PC.
Federal Trade Commission staff will no doubt characterize its recent complaint against Qualcomm as the mere application of traditional antitrust principles to conduct that just happens to involve intellectual property licensing. If that were the case, then it should have been uncontroversial to include a discussion of these practices in the revised guidelines released four days earlier, say attorneys with Mintz Levin Cohn Ferris Gl... (continued)
The Patent Trial and Appeal Board’s recent decisions denying institution of inter partes reviews based on insufficient evidence of obviousness provide patent owners with guidance on how to increase their chances of obtaining institution denials, says Denis Sullivan, leader of Barclay Damon LLP's intellectual property group.
The Second Circuit's recent decision in TCA Television v. McCollum could signal a trend toward requiring the use of the copyrighted work itself — apart from the larger work into which it is incorporated — to be transformative, say Jordan Grotzinger and Rebekah Guyon of Greenberg Traurig LLP.
2016 was a notable year for the Judicial Panel for Multidistrict Litigation: It created only 26 new MDL proceedings, a low-water mark for new MDL proceedings not seen in almost a quarter of a century. In this installment of his bimonthly series on the panel, Alan Rothman of Arnold & Porter Kaye Scholer LLP looks at the panel’s activity over the past year.
The Korean Fair Trade Commission's antitrust fines against Qualcomm last month provide insight into how Korea views a fair, reasonable and nondiscriminatory encumbrance, showing that Korea's perspective is rooted in policy, not contract, say attorneys with Mintz Levin Cohn Ferris Glovsky & Popeo PC.
We expect the change in pharmaceutical antitrust enforcement from the Obama administration to the Trump administration will most likely resemble that of the Bush administration vis-a-vis the Clinton administration — a continued focus on enforcing antitrust laws, but a decrease in volume in exchange for enhanced attention on specific regulatory objectives, say attorneys with Wilson Sonsini Goodrich & Rosati PC.
A ruling last month by China's highest court may be only a partial victory for Michael Jordan and Nike, but it is a great step forward for China’s trademark system. Eight messages from the decision are comforting and reassuring, say Amy Hsiao of Finnegan Henderson Farabow Garrett & Dunner LLP and Christopher Shen of NTD Patent & Trademark Agency Ltd.
President Donald Trump’s competition policies are sure to top the headlines in 2017. We can expect renewed focus on the SMARTER Act, continued attention to the pharmaceutical industry, and hurdles for foreign investment in the U.S., say attorneys with Cooley LLP.
Last week, the U.S. Supreme Court heard oral argument in Lee v. Tam to decide whether the Trademark Act’s prohibition on registering “disparaging” marks violates the First Amendment. The court heaped a good deal of skepticism toward both sides, perhaps a little more against the government, says Ann Dunn Wessberg, chairwoman of Fredrikson & Byron PA's trademark group and former chief trademark counsel for Target.